BIN1 and Alzheimer disease: We recently demonstrated that inhibiting Tau-SH3 interactions can reduce Aβ toxicity (Rush et al., 2020), and it is notable that BIN1 joins a growing list of SH3 domain–containing proteins that interact with Tau and are implicated in AD.